Briakinumab Biosimilar - Research Grade: Dylight®488

Briakinumab Biosimilar - Research Grade: Dylight®488, Host: CHO Cells, Human IgG1(E356D/M358L)-Kappa

Target: CD30.

Specificity: Detects human CD30.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Concentration: 0.2mg/ml.

Formulation: This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.

Purity: >95% by SDS-PAGE.

Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• SKU: ICH5188D488-100UG
• Manufacturer: Ichorbio
• Manufacturer SKU: ICH5188D488-100UG
• Package Unit: 100μg
• Quantity Unit: STK
• Reactivity: Human
• Clonality: Monoclonal
• Application: Functional Assay
• Isotype: Human IgG1(E356D/M358L)-Kappa
• Host: Cell Line